DOA
STJ

D'Orazio & Associates’s St Jude Medical STJ Stock Holding History

D'Orazio & Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$8K – 307
2016
Q4 		$8K Hold
100
– – ﹤0.01% 220
2016
Q3 		$7K Hold
100
– – ﹤0.01% 225
2016
Q2 		$8K Buy
+100
New +$7.13K ﹤0.01% 227

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

D'Orazio & Associates's STJ Position: Q1 2017 in Review

D'Orazio & Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 100 shares — an estimated $8K sold.

D'Orazio & Associates first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $8K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • D'Orazio & Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • D'Orazio & Associates sold 100 St Jude Medical shares in Q1 2017, an estimated $8K.
  • D'Orazio & Associates first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • D'Orazio & Associates's St Jude Medical position peaked at $8K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on D'Orazio & Associates's 13F filing for Q1 2017, filed 16 May 2017.